4 med tech stocks with improving prognosis for 2024
Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to dissipate, and the growth outlook was uncertain, leaving the market for their stock without a solid catalyst…
#jnj #medtech #yoy #kenvue #johnsonjohnson #abbottlaboratories #abt #q4 #abbott #freestylelibre